A continuación, se refleja información de los artículos del IMIBIC del 2022 más citados:
1. Título: “Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV) a randomised controlled trial”
Revista: Lancet
Espacio Web: http://dx.doi.org/10.1016/S0140-6736(22)00122-2
2. Título: “Orthohepevirus C infection as an emerging cause of acute hepatitis in Spain: First report in Europe”
Revista: Journal of Hepatology
Espacio Web: http://dx.doi.org/10.1016/j.jhep.2022.01.028
3. Título: “Stand-Alone Use of Artificial Intelligence for Digit Mammography and Digital Breast Tomosynthesis Screening: A Retrospective Evaluation”
Revista: Radiology
Espacio Web: http://dx.doi.org/10.1148/radiol.211590
4. Título: “Early programming of reproductive health and fertility: novel neuroendocrine mechanisms and implications in reproductive medicine”
Revista: Human Reproduction Update
Espacio Web: http://dx.doi.org/10.1093/humupd/dmac005
5. Título: “Immunoguided Discontinuation of Prophylaxis for Cytomegalovirus Disease in Kidney Transplant Recipients Treated With Antithymocyte Globulin: A Randomized Clinical Trial”
Revista: Clinical Infectious Diseases
Espacio Web: http://dx.doi.org/10.1093/cid/ciab574